Company Description
Bespoke Extracts, Inc. (OTCQB: BSPK), operating as The Joint Company, is a Colorado-based business focused on the regulated cannabis market in the United States. According to company disclosures and press releases, Bespoke centers its operations on the production of branded and white-label pre-rolled cannabis joints and related processing services for licensed dispensaries in Colorado. The company reports that its Colorado business has been rebranded under The Joint Company and emphasizes disciplined execution, brand development, and manufacturing efficiency in a competitive cannabis environment.
Core Operations and Business Focus
Through its subsidiary Bespoke Extracts Colorado, LLC, the company operates a marijuana-infused products manufacturing facility in Aurora, Colorado. Bespoke states that this facility produces pre-rolled joints and provides joint production and processing services to licensed dispensaries in the state. The company reports that direct sales of branded pre-rolled joints and expanded joint production services are key drivers of its revenue. Bespoke highlights its focus on cost efficiencies in raw materials, packaging, and labor, which it links to improvements in gross margins over time.
Bespoke has described its Colorado operations as a platform for The Joint Company brand, under which it has developed a portfolio of pre-roll products. The company reports that it produces high volumes of pre-rolls and that production growth has been an important element of its strategy. It has also indicated that it serves third-party clients through processing arrangements, contributing to additional revenue streams within the regulated cannabis market.
Brands and Product Lines
In its public communications, Bespoke identifies several branded pre-roll product lines under The Joint Company umbrella. The company describes Fresh Joints as its core brand and notes that this line has shown continued year-over-year growth and meaningful contribution to product revenue. Bespoke also reports the launch and growth of two additional brands, Doobskis and Dutch Blunts, which it states have achieved market penetration and traction with retail partners in Colorado.
According to management commentary, these brands are positioned within Colorado’s regulated cannabis market, with Fresh Joints highlighted for quality and volume growth in the pre-roll category. The company has described itself as a multi-brand pre-roll house within Colorado, with each brand contributing to a diversified pre-roll offering. Bespoke also notes that it has a third-party processing business that has experienced growth, driven by new client contracts.
Strategic Rebranding and Evolution
Bespoke reports that in the first quarter of 2025 it completed a strategic rebranding of its product offerings under The Joint Company (TJC). This rebranding is described as a pivotal step in its growth strategy, aligning its Colorado manufacturing and brand portfolio under a unified identity. The company indicates that TJC scaled its white-label processing business and launched the Doobskis and Dutch Blunts brands as part of this transition, while continuing to grow the Fresh Joints line.
Earlier company communications show that Bespoke’s history includes activity in hemp-derived CBD products and consumer products in CBD and regulated cannabis. Prior press releases describe Bespoke as a producer of high quality, hemp-derived CBD products and as a company focusing on consumer products in regulated cannabis and CBD. Over time, the company’s disclosures emphasize a shift toward regulated cannabis operations in Colorado, including infused products manufacturing and pre-roll production.
Regulated Cannabis Market Positioning
Bespoke’s public statements describe its strategy as focused on operating within state-regulated cannabis markets, beginning with Colorado. The company has reported efforts to expand its Colorado presence through acquisitions and regulatory approvals. For example, it announced signing definitive documents to acquire the assets of Wonderleaf, LLC, a licensed marijuana-infused products manufacturer in Denver, Colorado, which it described as marking its entry into the regulated cannabis business. Bespoke also announced a definitive agreement to acquire the assets of Osiris, LLC doing business as Best Day Ever, a vertically integrated Colorado cannabis licensee with cultivation and retail operations in Aspen and Glenwood Springs, Colorado.
The company has further disclosed that the Colorado Marijuana Enforcement Division granted it Suitability approval, enabling Bespoke to acquire businesses licensed by the MED, subject to final state and local approvals. Bespoke has characterized these regulatory milestones and proposed acquisitions as important components of its Colorado growth plans, including potential vertical integration and expanded capabilities in cultivation, retail, and infused products.
Manufacturing, Efficiency, and Operations
In multiple financial results releases, Bespoke highlights operational metrics related to pre-roll production and manufacturing efficiency. The company reports producing record numbers of pre-rolls in successive quarters and links higher production volumes to revenue growth. It also emphasizes improvements in gross margin, which it attributes to efficiencies in materials, labor, and packaging, as well as enhanced manufacturing processes.
Management commentary describes the company’s approach as focused on process improvements, data-driven iteration, and cost management. Bespoke notes that it has achieved cost efficiencies while also investing in marketing, sampling for new product launches, and customer acquisition. The company presents these operational changes as evidence of its ability to scale pre-roll production and support both its own brands and third-party processing clients.
Capital Markets and Corporate Status
Bespoke Extracts, Inc. is incorporated in Nevada, as reflected in its SEC filings. The company’s common stock trades on the OTCQB Venture Market under the symbol BSPK. Bespoke has stated that its uplisting from the OTC Pink Open Market to the OTCQB was intended to increase visibility and enhance trading liquidity, while also reflecting its focus on compliance and financial reporting.
The company has also disclosed capital-raising activities, including a private placement of common stock to an accredited investor, which it stated would be used for working capital purposes. In an 8-K filing, Bespoke reported entering into an amendment to a senior note with a principal amount of $849,500, extending the maturity date while keeping other material terms in place. These disclosures provide context on the company’s financing arrangements and obligations.
Regulatory Filings and Reporting
Bespoke files periodic reports and current reports with the U.S. Securities and Exchange Commission. The company has furnished press releases announcing quarterly financial results via Form 8-K, including results for the quarters ended March 31, June 30, and September 30, 2025. These filings include consolidated balance sheets and statements of operations that detail revenue, cost of products sold, operating expenses, interest expense, and net loss, as well as information on assets, liabilities, and stockholders’ deficit.
In its filings, Bespoke identifies itself as an emerging growth company and notes that it has elected certain reporting accommodations available under applicable securities laws. The company’s disclosures emphasize that its financial results are prepared in accordance with U.S. generally accepted accounting principles (GAAP) and that its SEC filings contain additional detail on its financial condition and results of operations.
Historical CBD and Brand Activities
Prior to its current emphasis on The Joint Company and Colorado pre-roll manufacturing, Bespoke publicly described itself as a producer of high quality, hemp-derived CBD products. Company communications from that period highlight a focus on tailoring CBD experiences for health and wellness-minded consumers, using hemp sourced from NSF-certified and USDA-certified organic producers in the United States, and employing industry-standard extraction methods.
Bespoke also disclosed marketing initiatives such as teaming with LEAF411, a nonprofit cannabis-trained nurse hotline, to provide customers with educational resources on the safe use of hemp-derived CBD products. The company announced brand ambassador relationships, including with professional mixed martial artist Mike “Platinum” Perry, to promote its CBD formulations. These historical activities illustrate the company’s earlier positioning in the CBD consumer products space before its strategic emphasis on regulated cannabis operations in Colorado.
Geographic Focus
Based on its public disclosures, Bespoke’s operational focus is centered on Colorado. The company identifies Aurora, Colorado as the location of its marijuana-infused products manufacturing facility and references Denver, Aspen, and Glenwood Springs, Colorado in connection with proposed acquisitions and existing or planned facilities. Bespoke has also stated that it is exploring potential expansion of The Joint Company model into other state-regulated cannabis markets, mentioning Massachusetts and New York as examples of markets under evaluation.
Risk and Regulatory Considerations
Bespoke’s press releases include cautionary language regarding forward-looking statements and note that its operations are subject to regulatory approvals and oversight in the jurisdictions where it operates. The company’s proposed acquisitions in Colorado are described as contingent on approvals from state and local regulatory agencies and on satisfaction of customary closing conditions. Its financial disclosures also reflect the risks associated with operating in a regulated cannabis market, including market contractions and competitive pressures in Colorado.
Summary
According to its public statements and SEC filings, Bespoke Extracts, Inc. has evolved from a hemp-derived CBD products company into a Colorado-focused regulated cannabis operator, with a particular emphasis on pre-rolled joints and processing services under The Joint Company brand. Its business model centers on manufacturing, branding, and processing within state-regulated cannabis markets, with Colorado serving as its primary operating base and proving ground for potential expansion into additional markets.
Stock Performance
Bespoke Extracts (BSPK) stock last traded at $0.2200. Over the past 12 months, the stock has gained 247.6%. At a market capitalization of $2.5M, BSPK is classified as a micro-cap stock with approximately 11.3M shares outstanding.
Latest News
Bespoke Extracts has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, acquisition, private placement. View all BSPK news →
SEC Filings
Bespoke Extracts has filed 5 recent SEC filings, including 1 Form 4, 1 Form 5, 1 Form NT 10-K, 1 Form 8-K. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BSPK SEC filings →
Financial Highlights
Bespoke Extracts generated $1.1M in revenue over the trailing twelve months, retaining a 40.5% gross margin, operating income reached -$995K (-89.0% operating margin), and net income was -$1.0M, reflecting a -92.8% net profit margin. Diluted earnings per share stood at $-0.10. The company generated -$290K in operating cash flow. With a current ratio of 0.15, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Bespoke Extracts (BSPK) currently stands at 8.7 thousand shares, down 2.2% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 249%. This relatively low short interest suggests limited bearish sentiment. With 42.9 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Bespoke Extracts (BSPK) currently stands at 42.9 days, up 1220% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 490.9% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 42.9 days.
BSPK Company Profile & Sector Positioning
Bespoke Extracts (BSPK) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BSPK often look at related companies in the same sector, including Tilt Hldgs Inc (TLLTF), Body And Mind Inc (BMMJ), Medical Mari (MJNA), Ctt Pharmaceutic (CTTH), and 4Front Ventures Corp (FFNTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BSPK's relative position within its industry.